Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
The company sent its disclosure form for the BOD & the shareholders' structure for the period ended on 30/09/2026 according to Article 30 of the Listing Rules.
The Disclosure Form (1,185 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
The company sent its disclosure form for the BOD & the shareholders' structure for the period ended on 30/09/2026 according to Article 30 of the Listing Rules.
The Disclosure Form (1,185 KB)